Of note, our study found that NOS1 is the most significantly up-regulated NOS in hypercholesterolemia-related CRC models, which means that NOS1 may act as an important regulator in the development of hypercholesterolemia-related CRC. The gene discussed is NOS2; the disease is colorectal carcinoma.